It is a trading private limited company based in Gwalior, Madhya Pradesh, India, established in 2002.
2002 | Gwalior, Madhya Pradesh, India | ActiveAllentis Pharmaceuticals Private Limited, a active private limited company, was established on 16 October 2002 in Gwalior, Madhya Pradesh, India. Engaging in other wholesale within the trade sector, it holds CIN: U24232MP2002PTC015334. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.95 M and a paid-up capital of ₹0.95 M.
It upholds a compliant status. Employing 32 professional, Its leadership includes Sanjay Mathur (Director), Manoj Kumar Gurnani (Director), Dilip Nathani (Director). Past directors included Manisha Agarkar. It holds ₹6.50 M open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sai Villa, Bhaskar Lane Jayendraganj, Gwalior, Madhya Pradesh, 474009.
U24232MP2002PTC015334
015334
16 October 2002
₹0.95 M
₹0.95 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Allentis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Mathur | Director | 16 Oct 2002 | Current |
| Manoj Kumar Gurnani | Director | 26 Feb 2003 | Current |
| Dilip Nathani | Director | 16 Oct 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Allentis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.9% decrease. The company also saw a substantial fall in profitability, with a 38.25% decrease in profit. The company's net worth moved up by a moderate rise of 9.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Allentis Pharmaceuticals had a public holding of 34.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2006 | Others | ₹6.50 M | Open |
| 09 Jan 2014 | Union Bank Of India | ₹1.00 M | Satisfied |
| 28 Dec 2006 | Union Bank Of India | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Allentis Pharmaceuticals has a workforce of 32 employees as of May 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Allentis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allentis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Allentis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Allentis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.
Progress on A charge registered on 09 Jan 2014 via Charge ID 10480778 with Union Bank Of India was fully satisfied on 18 Apr 2023. was documented.
Progress on A charge registered on 28 Dec 2006 via Charge ID 10033107 with Union Bank Of India was fully satisfied on 18 Apr 2023. was documented.
Progress on A charge with Others of Rs. 6.50 M registered on 22 Mar 2006 with Charge ID 80021745 was modified on 21 Jun 2016. was documented.
A charge with Union Bank Of India amounted to Rs. 1.00 M with Charge ID 10480778 was registered on 09 Jan 2014. was recorded as a recent event.
The CIN of Allentis Pharmaceuticals Private Limited is U24232MP2002PTC015334.
Allentis Pharmaceuticals Private Limited is headquartered at Sai Villa, Bhaskar Lane Jayendraganj, Gwalior, Madhya Pradesh, 474009.
Allentis Pharmaceuticals Private Limited was incorporated on 16 October 2002.
The current directors of Allentis Pharmaceuticals Private Limited are
The primary industry of Allentis Pharmaceuticals Private Limited is Trade.
Allentis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Allentis Pharmaceuticals Private Limited is ₹0.95 M, and the paid-up capital is ₹0.95 M.
The compliance status of Allentis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX